Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Endocrinol., 20 August 2025

Sec. Cardiovascular Endocrinology

Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1663787

Correction: A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review

This article is a correction to:

  1. A Decade of Progress in Type 2 Diabetes and Cardiovascular Disease: Advances in SGLT2 Inhibitors and GLP-1 Receptor Agonists -A comprehensive Review

    1. Read original article
David Aristizbal-Colorado,David Aristizábal-Colorado1,2David Corredor-Rengifo,David Corredor-Rengifo1,2Santiago Sierra-CastilloSantiago Sierra-Castillo3Carolina Lpez-CorredorCarolina López-Corredor4David-Alexander Vernaza-Trujillo,,David-Alexander Vernaza-Trujillo2,5,6Danilo Weir-RestrepoDanilo Weir-Restrepo7Juan S. Izquierdo-Condoy*Juan S. Izquierdo-Condoy8*Esteban Ortiz-PradoEsteban Ortiz-Prado8Jorge Rico-Fontalvo,Jorge Rico-Fontalvo9,10Juan-Esteban Gmez-Mesa,Juan-Esteban Gómez-Mesa11,12Alin Abreu-LombaAlin Abreu-Lomba13Wilfredo-Antonio Rivera-Martínez,Wilfredo-Antonio Rivera-Martínez2,14
  • 1Internal Medicine Department, Universidad Libre, Cali, Colombia
  • 2Grupo Interinstitucional de Medicina Interna (GIMI1), Universidad Libre, Cali, Colombia
  • 3Epidemiology Department, Universidad Centros de Estudios en Salud (CES), Medellín, Colombia
  • 4Medicine Program, Universidad Santiago de Cali, Cali, Colombia
  • 5Department of Public Health, Pontificia Universidad Javeriana, Cali, Colombia
  • 6Clinical Research Center, Clínica Imbanaco, Cali, Colombia
  • 7Internal Medicine Department, Universidad Centros de Estudios en Salud (CES), Medellin, Colombia
  • 8One Health Research Group, Universidad de las Américas, Quito, Ecuador
  • 9Department of Nephrology, Faculty of Medicine, Universidad Simón Bolívar, Barranquilla, Colombia
  • 10Latin American Society of Nephrology and Arterial Hypertension (SLANH), Ciudad de Panama, Panama
  • 11Cardiology Department, Fundación Valle del Lili, Cali, Colombia
  • 12Department of Health Sciences, Universidad Icesi, Cali, Colombia
  • 13Endocrinology Department, Clínica Imbanaco, Cali, Colombia
  • 14Endocrinology Department, Universidad de Antioquia, Medellín, Colombia

A Correction on
A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review

By Aristizábal-Colorado D, Corredor-Rengifo D, Sierra-Castillo S, López-Corredor C, Vernaza-Trujillo D-A, Weir-Restrepo D, Izquierdo-Condoy JS, Ortiz-Prado E, Rico-Fontalvo J, Gómez-Mesa J-E, Abreu-Lomba A and Rivera-Martínez W-A (2025) Front. Endocrinol. 16:1605746. doi: 10.3389/fendo.2025.1605746

The affiliations “Department of Public Health, Pontificia Universidad Javeriana, Cali, Colombia” and “Clinical Research Center, Clı́nica Imbanaco, Cali, Colombia” were omitted for author David Alexander Vernaza Trujillo.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cardiovascular outcomes, SGLT2 inhibitors, GLP-1 agonists, combination therapy, heart failure, renal outcomes

Citation: Aristizábal-Colorado D, Corredor-Rengifo D, Sierra-Castillo S, López-Corredor C, Vernaza-Trujillo D-A, Weir-Restrepo D, Izquierdo-Condoy JS, Ortiz-Prado E, Rico-Fontalvo J, Gómez-Mesa J-E, Abreu-Lomba A and Rivera-Martínez W-A (2025) Correction: A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review. Front. Endocrinol. 16:1663787. doi: 10.3389/fendo.2025.1663787

Received: 10 July 2025; Accepted: 28 July 2025;
Published: 20 August 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Aristizábal-Colorado, Corredor-Rengifo, Sierra-Castillo, López-Corredor, Vernaza-Trujillo, Weir-Restrepo, Izquierdo-Condoy, Ortiz-Prado, Rico-Fontalvo, Gómez-Mesa, Abreu-Lomba and Rivera-Martínez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Juan S. Izquierdo-Condoy, anVhbjFpenF1aWVyZG8xMUBnbWFpbC5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.